Abstract:Proc Amer Assoc Cancer Res, Volume 46, 2005 2560 Nucleotide excision repair (NER) is one of the major DNA repair pathways in mammalian cells, involved in the removal of a wide variety of DNA lesions including bulky carcinogen adducts from tobacco exposure. Polymorphisms in NER genes may influence DNA repair capacity and confer cancer susceptibility. To explore the association between these polymorphisms and lung cancer risk, we examined ten polymorphisms in six major NER genes in 1396 lung cancer patients and 1423 age-, gender- and smoking-matched controls. The specific polymorphic loci examined include: XPA (A/G at 5’ UTR), XPC (polyAT, Ala499Val, Lys939Gln), XPD (Asp312Asn, Lys751Gln), XPF (Ser662Pro), XPG (His1104Asp), ERCC6 (Met1097Val, Arg1230Pro). For main effects of the individual polymorphisms, only the variant XPA alleles had a significant impact on lung cancer risk (OR=0.80, 95%: 0.64-0.99). There were no statistically significant differences in the distributions of the other polymorphisms between the cases and the controls. However, there was a significant trend for an increased risk of lung cancer with an increasing number of putative high-risk alleles. Using individuals with less than 3 putative high-risk alleles as the reference group, individuals with 3, 4 and more than 4 risk alleles had adjusted ORs of 1.14 (0.87-1.49), 1.40 (1.08-1.81) and 1.68 (1.32-2.12), respectively, ( P for trend < 0.000). When we dichotoimized the subjects at ≥4 or <4 putative risk alleles, individuals with ≥4 risk alleles had a significantly elevated lung cancer risk (OR=1.46, 95%: 1.24-1.73) as compared to those with <4 risk alleles. The risk was more evident in men (OR=1.72, 95%: 1.35-2.18) compared to women (OR=1.25, 95%: 0.98-1.58); in younger individuals (OR=1.63, 95%: 1.27-2.09) compared to older individuals (OR=1.31, 95%: 1.04-1.65); in ever smokers (OR=1.52, 95%: 1.27-1.81) compared to never smokers (OR=1.11, 95%: 0.74-1.81); and in heavy smokers (OR=1.88, 95%: 1.48-2.39) compared to light smokers (OR=1.14, 95%: 0.90-1.45). This large study offers a pathway-based analysis of multiple polymorphic genes and the data suggest that individuals with higher number of genetic variations in DNA repair genes in a common pathway are at increased risk for lung cancer, confirming the importance of taking a pathway-based approach to risk assessment. Supported by NCI grants CA 55769, CA 70907 and CA 86390 .

Associations Between Expression Levels of Nine Core Nucleotide Excision Repair Genes in Lymphocytes and Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population

Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population

Nucleotide Excision Repair Proteins and Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population

Associations Between Expression Levels of Nucleotide Excision Repair Proteins in Lymphoblastoid Cells and Risk of Squamous Cell Carcinoma of the Head and Neck.

Transcriptomic Model-Based Lncrnas and Mrnas Serve As Independent Prognostic Indicators in Head and Neck Squamous Cell Carcinoma

Reduced Mrna Expression of Nucleotide Excision Repair Genes in Lymphocytes and Risk of Squamous Cell Carcinoma of the Head and Neck.

The Association Between Polymorphisms in the DNA Nucleotide Excision Repair Genes and RRM1 Gene and Lung Cancer Risk.

Association Between Nucleotide Excision Repair Gene Polymorphism and Colorectal Cancer Risk

Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population.

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy

Nucleotide Excision Repair Pathway Gene Polymorphisms Are Linked to Breast Cancer Risk in a Chinese Population

ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis

Identification Of Genetic Variants In Base Excision Repair Pathway And Their Associations With Risk Of Esophageal Squamous Cell Carcinoma

Genetic Variants in Nucleotide Excision Repair Pathway Predict Survival of Esophageal Squamous Cell Cancer Patients Receiving Platinum‐based Chemotherapy

Nucleotide excision repair genes and lung cancer risk: A pathway-based approach

Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China

Genetic Variants Associated with Expression of TCF19 Contribute to the Risk of Head and Neck Cancer in Chinese Population.

Polymorphisms In Excision Repair Cross-Complementing Group 4 (Ercc4) And Susceptibility To Primary Lung Cancer In A Chinese Han Population

Polymorphisms in the Ercc5 Gene and Risk of Esophageal Squamous Cell Carcinoma (escc) in Eastern Chinese Populations

Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study

Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population.